Key Details
Price
$2.03Annual ROE
-31.49%Beta
2.34Events Calendar
Next earnings date:
Jan 31, 2025Recent quarterly earnings:
Nov 06, 2024Recent annual earnings:
Aug 14, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
ARAY's first-quarter fiscal 2025 earnings meet estimates. Both the top and bottom lines deteriorate year over year.
Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript
MADISON, Wis., Oct. 23, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2025, ended September 30, 2024, during a conference call hosted by company management at 1:30 p.m.
MADISON, Wis. , Oct. 21, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Michael Murphy, CPA has joined the company as Vice President, Corporate Controller.
ARAY's solid product demand and revenue growth raise optimism about the stock.
Accuray is the first industry partner to open a facility at the Genolier Innovation Hub, created to provide opportunities for clinician-industry collaborations that can help accelerate improvements in patient care New Accuray CyberComm™ tool was used to significantly reduce the CyberKnife® S7™ System's commissioning time and enable product training in Genolier to begin more quickly MADISON, Wis. , Sept. 30, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the initiation of CyberKnife® S7™ System medical professional training at its education center located within the newly opened Genolier Innovation Hub, a fully-owned subsidiary of AEVIS VICTORIA SA, in Switzerland.
ARAY's solid product demand and revenue growth raise optimism about the stock.
The latest adoption of Accuray's Radixact System and VitalHold package is likely to improve the care provided to cancer patients and their experience.
MADISON, Wis. , Sept. 3, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that President and Chief Executive Officer Suzanne Winter will be taking a temporary medical leave of absence to receive care for a treatable form of cancer, effective immediately.
Developed for India and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priority Drives the next phase of company's strategic plan to expand its portfolio of helical radiation therapy delivery systems MADISON, Wis. , Aug. 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has received CE Mark for Accuray Helix™, a CT-guided helical radiotherapy system designed to provide high-performance and high-throughput.
FAQ
- What is the primary business of Accuray Incorporated?
- What is the ticker symbol for Accuray Incorporated?
- Does Accuray Incorporated pay dividends?
- What sector is Accuray Incorporated in?
- What industry is Accuray Incorporated in?
- What country is Accuray Incorporated based in?
- When did Accuray Incorporated go public?
- Is Accuray Incorporated in the S&P 500?
- Is Accuray Incorporated in the NASDAQ 100?
- Is Accuray Incorporated in the Dow Jones?
- When was Accuray Incorporated's last earnings report?
- When does Accuray Incorporated report earnings?
- Should I buy Accuray Incorporated stock now?